HOLX
Hologic, Inc.$76.01+0.36 (+0.48%)Prev Close$75.65·MCap$16.97B·P/E31.67·Vol70.55M·Yield—
▲
Buys (12M)
1
$300.8K
▼
Sells (12M)
21
$16.78M
◆
Net Activity
Net Seller
$16.48M
●
Active Insiders
11
last 12 mo
Over the past 12 months, insider activity at Hologic, Inc. (HOLX) has been dominated by selling, with 1 insider purchase totaling $300.8K and 21 insider sales totaling $16.78M. The most recent insider transaction was by De Walt Diana (SVP, Human Resources), who sold $330.9K worth of shares on Feb 3, 2026. Hologic, Inc. operates in the Healthcare sector, within the Medical - Instruments & Supplies industry, with a market cap of $16.97B.
HOLX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | De Walt Diana | SVP, Human Resources | Sell | 4,416 | $74.93 | $330.9K | 0 |
| Dec 16, 2025 | Schnittker Brandon | President, GYN Surgical | Sell | 90 | $75.00 | $6.8K | 0 |
| Nov 18, 2025 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 187 | $74.15 | $13.9K | 0 |
| Nov 18, 2025 | Liddy Anne M. | General Counsel | Sell | 337 | $74.15 | $25.0K | 0 |
| Nov 18, 2025 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 6,874 | $74.15 | $509.7K | 0 |
| Nov 18, 2025 | Mitchell Essex D | Chief Operating Officer | Sell | 1,342 | $74.15 | $99.5K | 0 |
| Nov 18, 2025 | Oberton Karleen Marie | Chief Financial Officer | Sell | 1,333 | $74.15 | $98.8K | 0 |
| Nov 18, 2025 | Schneiders Jennifer M | President, Diag. Solutions | Sell | 561 | $74.15 | $41.6K | 0 |
| Nov 18, 2025 | Schnittker Brandon | President, GYN Surgical | Sell | 178 | $74.15 | $13.2K | 0 |
| Nov 18, 2025 | Verstreken Jan | Group President, International | Sell | 196 | $74.15 | $14.5K | 0 |
| Nov 12, 2025 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 1,259 | $74.17 | $93.4K | 0 |
| Nov 12, 2025 | Liddy Anne M. | General Counsel | Sell | 694 | $74.39 | $51.6K | 0 |
| Nov 12, 2025 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 57,084 | $74.16 | $4.23M | 0 |
| Nov 12, 2025 | Mitchell Essex D | Chief Operating Officer | Sell | 5,628 | $74.25 | $417.9K | 0 |
| Nov 12, 2025 | Oberton Karleen Marie | Chief Financial Officer | Sell | 10,876 | $74.17 | $806.6K | 0 |
| Nov 12, 2025 | Schneiders Jennifer M | President, Diag. Solutions | Sell | 860 | $74.51 | $64.1K | 0 |
| Nov 12, 2025 | Schnittker Brandon | President, GYN Surgical | Sell | 427 | $74.44 | $31.8K | 0 |
| Nov 12, 2025 | Verstreken Jan | Group President, International | Sell | 1,598 | $74.16 | $118.5K | 0 |
| Oct 22, 2025 | Stamoulis Christiana | Director | Sell | 7,402 | $73.07 | $540.9K | 0 |
| Sep 23, 2025 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 138,358 | $66.97 | $9.27M | 0 |
| Jun 3, 2025 | Schnittker Brandon | Div. President, GYN Surgical | Sell | 69 | $62.17 | $4.3K | 0 |
| May 9, 2025 | Madaus Martin D | Director | Buy | 5,445 | $55.24 | $300.8K | 0 |
| Dec 6, 2024 | Mitchell Essex D | Chief Operating Officer | Sell | 24,856 | $76.34 | $1.90M | 27,957-47% |
| Sep 3, 2024 | Oberton Karleen Marie | Chief Financial Officer | Sell | 52,679 | $80.56 | $4.24M | 84,042-39% |
| Aug 8, 2024 | Schnittker Brandon | Div. President, GYN Surgical | Sell | 476 | $83.11 | $39.6K | 3,735 |
| Aug 5, 2024 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 5,093 | $81.99 | $417.6K | 10,476-33% |
| Aug 1, 2024 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 44,039 | $81.70 | $3.60M | 1,193,967 |
| Jul 19, 2024 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 3,672 | $80.13 | $294.2K | 1,157,562 |
| Jul 19, 2024 | Stamoulis Christiana | Director | Sell | 9,039 | $79.50 | $718.6K | 45,472 |
| Mar 15, 2024 | GARRETT SCOTT T | Director | Sell | 16,441 | $75.50 | $1.24M | 48,611-25% |
| Mar 11, 2024 | CRAWFORD SALLY | Director | Sell | 9,039 | $76.40 | $690.6K | 132,927 |
| Mar 11, 2024 | Dockendorff Charles J | Director | Sell | 1,465 | $76.21 | $111.6K | 1,572-48% |
| Jan 30, 2024 | Oberton Karleen Marie | Chief Financial Officer | Sell | 14,940 | $75.00 | $1.12M | 103,916 |
| Jan 4, 2024 | Dockendorff Charles J | Director | Sell | 16,017 | $72.00 | $1.15M | 1,465-92% |
| Dec 13, 2023 | GARRETT SCOTT T | Director | Sell | 10,000 | $68.71 | $687.1K | 47,039 |
| Dec 1, 2023 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 47,711 | $70.41 | $3.36M | 1,239,088 |
| Nov 24, 2023 | Mitchell Essex D | Div. President, GYN Surgical | Sell | 7,500 | $71.85 | $538.9K | 12,827-37% |
| Jun 20, 2023 | GARRETT SCOTT T | Director | Sell | 10,000 | $79.72 | $797.2K | 57,039 |
| May 9, 2023 | Mitchell Essex D | Div. President, GYN Surgical | Sell | 2,390 | $83.73 | $200.1K | 7,212 |
| Feb 9, 2023 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 9,128 | $85.28 | $778.4K | 14,298-39% |
| Dec 16, 2022 | Hellmann Elisabeth A | SVP, Human Resources | Sell | 1,649 | $76.40 | $126.0K | 8,545 |
| Dec 2, 2022 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 33,500 | $75.65 | $2.53M | 2,326,471 |
| Nov 17, 2022 | Thornal Kevin R | Group Pres, Global Diagnostics | Sell | 19,118 | $75.32 | $1.44M | 62,368 |
| Nov 16, 2022 | Griffin John M. | General Counsel | Sell | 26,902 | $76.12 | $2.05M | 172,212 |
| Nov 14, 2022 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 138,422 | $75.71 | $10.48M | 2,486,718 |
| Nov 3, 2022 | Oberton Karleen Marie | Chief Financial Officer | Sell | 14,545 | $72.50 | $1.05M | 126,811 |
| May 19, 2022 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 3,844 | $78.75 | $302.7K | 13,532 |
| May 19, 2022 | Verstreken Jan | Group President, International | Sell | 6,500 | $78.80 | $512.2K | 64,191 |
| May 17, 2022 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 7,052 | $75.49 | $532.4K | 13,532-34% |
| May 5, 2022 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 2,178 | $74.18 | $161.6K | 13,532 |
Showing 1–50 of 55
1 / 2
HOLX Insider Buying Activity
The following table shows recent insider purchases of Hologic, Inc. (HOLX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 9, 2025 | Madaus Martin D | Director | Buy | 5,445 | $55.24 | $300.8K | 0 |
HOLX Insider Selling Activity
The following table shows recent insider sales of Hologic, Inc. (HOLX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | De Walt Diana | SVP, Human Resources | Sell | 4,416 | $74.93 | $330.9K | 0 |
| Dec 16, 2025 | Schnittker Brandon | President, GYN Surgical | Sell | 90 | $75.00 | $6.8K | 0 |
| Nov 18, 2025 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 187 | $74.15 | $13.9K | 0 |
| Nov 18, 2025 | Liddy Anne M. | General Counsel | Sell | 337 | $74.15 | $25.0K | 0 |
| Nov 18, 2025 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 6,874 | $74.15 | $509.7K | 0 |
| Nov 18, 2025 | Mitchell Essex D | Chief Operating Officer | Sell | 1,342 | $74.15 | $99.5K | 0 |
| Nov 18, 2025 | Oberton Karleen Marie | Chief Financial Officer | Sell | 1,333 | $74.15 | $98.8K | 0 |
| Nov 18, 2025 | Schneiders Jennifer M | President, Diag. Solutions | Sell | 561 | $74.15 | $41.6K | 0 |
| Nov 18, 2025 | Schnittker Brandon | President, GYN Surgical | Sell | 178 | $74.15 | $13.2K | 0 |
| Nov 18, 2025 | Verstreken Jan | Group President, International | Sell | 196 | $74.15 | $14.5K | 0 |
| Nov 12, 2025 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 1,259 | $74.17 | $93.4K | 0 |
| Nov 12, 2025 | Liddy Anne M. | General Counsel | Sell | 694 | $74.39 | $51.6K | 0 |
| Nov 12, 2025 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 57,084 | $74.16 | $4.23M | 0 |
| Nov 12, 2025 | Mitchell Essex D | Chief Operating Officer | Sell | 5,628 | $74.25 | $417.9K | 0 |
| Nov 12, 2025 | Oberton Karleen Marie | Chief Financial Officer | Sell | 10,876 | $74.17 | $806.6K | 0 |
| Nov 12, 2025 | Schneiders Jennifer M | President, Diag. Solutions | Sell | 860 | $74.51 | $64.1K | 0 |
| Nov 12, 2025 | Schnittker Brandon | President, GYN Surgical | Sell | 427 | $74.44 | $31.8K | 0 |
| Nov 12, 2025 | Verstreken Jan | Group President, International | Sell | 1,598 | $74.16 | $118.5K | 0 |
| Oct 22, 2025 | Stamoulis Christiana | Director | Sell | 7,402 | $73.07 | $540.9K | 0 |
| Sep 23, 2025 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 138,358 | $66.97 | $9.27M | 0 |
| Jun 3, 2025 | Schnittker Brandon | Div. President, GYN Surgical | Sell | 69 | $62.17 | $4.3K | 0 |
| Dec 6, 2024 | Mitchell Essex D | Chief Operating Officer | Sell | 24,856 | $76.34 | $1.90M | 27,957-47% |
| Sep 3, 2024 | Oberton Karleen Marie | Chief Financial Officer | Sell | 52,679 | $80.56 | $4.24M | 84,042-39% |
| Aug 8, 2024 | Schnittker Brandon | Div. President, GYN Surgical | Sell | 476 | $83.11 | $39.6K | 3,735 |
| Aug 5, 2024 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 5,093 | $81.99 | $417.6K | 10,476-33% |
| Aug 1, 2024 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 44,039 | $81.70 | $3.60M | 1,193,967 |
| Jul 19, 2024 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 3,672 | $80.13 | $294.2K | 1,157,562 |
| Jul 19, 2024 | Stamoulis Christiana | Director | Sell | 9,039 | $79.50 | $718.6K | 45,472 |
| Mar 15, 2024 | GARRETT SCOTT T | Director | Sell | 16,441 | $75.50 | $1.24M | 48,611-25% |
| Mar 11, 2024 | CRAWFORD SALLY | Director | Sell | 9,039 | $76.40 | $690.6K | 132,927 |
| Mar 11, 2024 | Dockendorff Charles J | Director | Sell | 1,465 | $76.21 | $111.6K | 1,572-48% |
| Jan 30, 2024 | Oberton Karleen Marie | Chief Financial Officer | Sell | 14,940 | $75.00 | $1.12M | 103,916 |
| Jan 4, 2024 | Dockendorff Charles J | Director | Sell | 16,017 | $72.00 | $1.15M | 1,465-92% |
| Dec 13, 2023 | GARRETT SCOTT T | Director | Sell | 10,000 | $68.71 | $687.1K | 47,039 |
| Dec 1, 2023 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 47,711 | $70.41 | $3.36M | 1,239,088 |
| Nov 24, 2023 | Mitchell Essex D | Div. President, GYN Surgical | Sell | 7,500 | $71.85 | $538.9K | 12,827-37% |
| Jun 20, 2023 | GARRETT SCOTT T | Director | Sell | 10,000 | $79.72 | $797.2K | 57,039 |
| May 9, 2023 | Mitchell Essex D | Div. President, GYN Surgical | Sell | 2,390 | $83.73 | $200.1K | 7,212 |
| Feb 9, 2023 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 9,128 | $85.28 | $778.4K | 14,298-39% |
| Dec 16, 2022 | Hellmann Elisabeth A | SVP, Human Resources | Sell | 1,649 | $76.40 | $126.0K | 8,545 |
| Dec 2, 2022 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 33,500 | $75.65 | $2.53M | 2,326,471 |
| Nov 17, 2022 | Thornal Kevin R | Group Pres, Global Diagnostics | Sell | 19,118 | $75.32 | $1.44M | 62,368 |
| Nov 16, 2022 | Griffin John M. | General Counsel | Sell | 26,902 | $76.12 | $2.05M | 172,212 |
| Nov 14, 2022 | MACMILLAN STEPHEN P | Chairman, President and CEO | Sell | 138,422 | $75.71 | $10.48M | 2,486,718 |
| Nov 3, 2022 | Oberton Karleen Marie | Chief Financial Officer | Sell | 14,545 | $72.50 | $1.05M | 126,811 |
| May 19, 2022 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 3,844 | $78.75 | $302.7K | 13,532 |
| May 19, 2022 | Verstreken Jan | Group President, International | Sell | 6,500 | $78.80 | $512.2K | 64,191 |
| May 17, 2022 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 7,052 | $75.49 | $532.4K | 13,532-34% |
| May 5, 2022 | COHN BENJAMIN JORDAN | Principal Accounting Officer | Sell | 2,178 | $74.18 | $161.6K | 13,532 |
HOLX Insiders
Similar Stocks to HOLX
ISRG
Intuitive Surgical, Inc.
$464.08-1.47%
$165.37B
BDX
Becton, Dickinson and Company
$148.87-0.90%
$57.47B
MDLN
Medline Inc.
$44.77-1.01%
$39.17B
RMD
ResMed Inc.
$217.12-2.21%
$33.01B
WST
West Pharmaceutical Services, Inc.
$293.01-3.04%
$19.79B
BAX
Baxter International Inc.
$18.15-1.84%
$9.45B
MASI
Masimo Corporation
$178.41-0.14%
$9.34B
ATR
AptarGroup, Inc.
$125.29+0.45%
$8.02B